STOCK TITAN

Agilent Authorizes $2 Billion Share Repurchase Program

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
buyback
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has announced a new share repurchase program, authorizing up to $2 billion to buy back its common stock starting March 1. This initiative replaces the existing program aimed at minimizing share dilution. CFO Bob McMahon emphasized that this program is crucial for balanced capital deployment, focusing on growth and delivering strong returns to shareholders. Repurchases will depend on various factors including stock price and market conditions.

Positive
  • Authorization of a new $2 billion share repurchase program enhances shareholder value.
  • The repurchase program aims to reduce share dilution and support stock price.
  • Demonstrates management's confidence in the company's growth and financial stability.
Negative
  • None.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company’s common stock.

“Agilent is committed to balanced capital deployment that drives growth and helps deliver strong returns for shareholders,” said Bob McMahon, Agilent chief financial officer. “This share repurchase program is a key element of that strategy.”

The new program will begin March 1. Upon commencement, the new repurchase program replaces Agilent’s existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs.

The number of shares to be repurchased and the timing of any repurchases will depend on factors such as the stock price, economic and market conditions, and corporate and regulatory requirements. The stock repurchase program may be suspended or discontinued at any time.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, statements regarding the company’s share repurchase programs. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent’s customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing; and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; the adverse impacts of and risks posed by the COVID-19 pandemic; and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the fiscal quarter ended October 31, 2022. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

Media Contact:

Sarah Litton

+1 669 255 7696

sarah.litton@agilent.com

Investor Contact:

Parmeet Ahuja

+1 408-345-8948

parmeet_ahuja@agilent.com

Source: Agilent Technologies Inc.

FAQ

What is the total amount authorized for Agilent's new share repurchase program?

Agilent's board has authorized a new share repurchase program totaling up to $2 billion.

When will Agilent's share repurchase program commence?

The new share repurchase program will begin on March 1.

What is the purpose of Agilent's share repurchase program?

The purpose of the program is to reduce share dilution and enhance shareholder returns.

How does Agilent's share repurchase program impact its stock price?

The program aims to support and potentially increase Agilent's stock price by reducing the number of shares outstanding.

Agilent Technologies Inc.

NYSE:A

A Rankings

A Latest News

A Stock Data

38.48B
286.42M
0.27%
91.2%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
SANTA CLARA